BFSG LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.44M | Sell |
51,280
-400
| -0.8% | -$10.6K | 0.14% | 146 |
|
|
2025
Q4 | $1.29M | Sell |
51,680
-138,200
| -73% | -$3.49M | 0.12% | 152 |
|
|
2025
Q3 | $4.84M | Buy |
189,880
+4,176
| +2% | +$103K | 0.47% | 65 |
|
|
2025
Q2 | $4.5M | Buy |
185,704
+995
| +0.5% | +$23.2K | 0.5% | 64 |
|
|
2025
Q1 | $4.68M | Buy |
184,709
+2,514
| +1% | +$65.8K | 0.57% | 61 |
|
|
2024
Q4 | $4.83M | Sell |
182,195
-90,977
| -33% | -$2.47M | 0.57% | 60 |
|
|
2024
Q3 | $7.91M | Sell |
273,172
-2,143
| -0.8% | -$62.5K | 0.92% | 26 |
|
|
2024
Q2 | $7.7M | Buy |
275,315
+119,447
| +77% | +$3.29M | 0.98% | 24 |
|
|
2024
Q1 | $4.33M | Sell |
155,868
-4,384
| -3% | -$122K | 0.57% | 59 |
|
|
2023
Q4 | $4.61M | Sell |
160,252
-8,552
| -5% | -$259K | 0.67% | 47 |
|
|
2023
Q3 | $5.6M | Buy |
168,804
+9,442
| +6% | +$334K | 0.91% | 29 |
|
|
2023
Q2 | $5.84M | Sell |
159,362
-1,956
| -1% | -$76.1K | 0.99% | 28 |
|
|
2023
Q1 | $6.58M | Buy |
161,318
+87,922
| +120% | +$3.8M | 1.21% | 19 |
|
|
2022
Q4 | $3.76M | Buy |
73,396
+896
| +1% | +$43K | 0.75% | 44 |
|
|
2022
Q3 | $3.17M | Sell |
72,500
-602
| -0.8% | -$29.3K | 0.67% | 58 |
|
|
2022
Q2 | $3.83M | Sell |
73,102
-306
| -0.4% | -$15.6K | 0.69% | 56 |
|
|
2022
Q1 | $3.8M | Sell |
73,408
-5,672
| -7% | -$294K | 0.6% | 59 |
|
|
2021
Q4 | $4.67M | Sell |
79,080
-5,052
| -6% | -$250K | 0.65% | 49 |
|
|
2021
Q3 | $3.62M | Sell |
84,132
-924
| -1% | -$40.9K | 0.55% | 60 |
|
|
2021
Q2 | $3.33M | Sell |
85,056
-2,898
| -3% | -$113K | 0.6% | 60 |
|
|
2021
Q1 | $3.19M | Sell |
87,954
-34,085
| -28% | -$1.21M | 0.52% | 63 |
|
|
2020
Q4 | $4.49M | Buy |
122,039
+4,984
| +4% | +$183K | 0.75% | 43 |
|
|
2020
Q3 | $4.08M | Buy |
117,055
+502
| +0.4% | +$17.6K | 0.76% | 45 |
|
|
2020
Q2 | $3.62M | Buy |
116,553
+883
| +0.8% | +$30K | 0.78% | 42 |
|
|
2020
Q1 | $3.58M | Buy |
115,670
+8,579
| +8% | +$292K | 0.92% | 37 |
|
|
2019
Q4 | $3.98M | Buy |
107,091
+7,116
| +7% | +$253K | 0.75% | 47 |
|
|
2019
Q3 | $3.36M | Buy |
99,975
+37,203
| +59% | +$1.35M | 0.75% | 44 |
|
|
2019
Q2 | $2.58M | Sell |
62,772
-412
| -0.7% | -$16.4K | 1.01% | 32 |
|
|
2019
Q1 | $2.55M | Sell |
63,184
-53
| -0.1% | -$2.12K | 0.95% | 33 |
|
|
2018
Q4 | $2.62M | Buy |
63,237
+50
| +0.1% | +$2.08K | 1.19% | 25 |
|
|
2018
Q3 | $2.64M | Sell |
63,187
-1,069
| -2% | -$41.2K | 1.11% | 32 |
|
|
2018
Q2 | $2.21M | Sell |
64,256
-466
| -0.7% | -$15.9K | 0.97% | 36 |
|
|
2018
Q1 | $2.18M | Sell |
64,722
-2
| -0% | -$69 | 0.97% | 35 |
|
|
2017
Q4 | $2.22M | Sell |
64,724
-748
| -1% | -$25.5K | 0.94% | 35 |
|
|
2017
Q3 | $2.22M | Sell |
65,472
-1,202
| -2% | -$38.6K | 1% | 32 |
|
|
2017
Q2 | $2.13M | Sell |
66,674
-458
| -0.7% | -$14.4K | 1.04% | 37 |
|
|
2017
Q1 | $2.18M | Buy |
+67,132
| New | +$2.12M | 1.1% | 32 |
|
Other funds holding PFE
VCM
VPM
BFSG LLC's PFE Position: Q1 2026 in Review
BFSG LLC reduced its Pfizer (PFE) stake by 0.77% in Q1 2026, selling an estimated $10.6K and leaving 51,280 shares worth $1.44M. The position accounts for 0.14% of the portfolio, ranked #146.
BFSG LLC first reported a position in PFE in Q1 2017 and has held it in 37 quarters since. The position peaked at $7.91M in Q3 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- BFSG LLC held 51,280 shares of Pfizer worth $1.44M as of Q1 2026.
- BFSG LLC sold 400 Pfizer shares in Q1 2026, an estimated $10.6K.
- Pfizer made up 0.14% of BFSG LLC's portfolio in Q1 2026, its #146 holding.
- BFSG LLC first reported a position in Pfizer in Q1 2017 and has held it in 37 quarters since.
- BFSG LLC's Pfizer position peaked at $7.91M in Q3 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on BFSG LLC's 13F filing for Q1 2026, filed 29 Apr 2026.